Join us on Patreon! https://www.patreon.com/MichaelLustgartenPhDDiscount Links/Affiliates: Blood testing (where I get the majority of my labs): https://www.u…
Earlier this month, Amazon announced the start of testing a new AI shopping agent, a feature it calls “Buy for Me”. OpenAI, Google, and Perplexity have also showcased AI shopping
Solar cells based on perovskites, materials with a characteristic crystal structure first unveiled in the mineral calcium titanate (CaTiO3), have emerged as a promising alternative to conventional silicon-based photovoltaics. A key advantage of these materials is that they could yield high power conversion efficiencies (PCEs), yet their production costs could be lower.
Perovskite films can exist in different structural forms, also referred to as phases. One is the so-called α-phase (i.e., a photoactive black phase), which is the most desirable phase for the efficient absorption of light and the transport of charge carriers. The δ-phase, on the other hand, is an intermediate phase characterized by a different atom arrangement and reduced photoactivity.
Researchers at the University of Toledo, Northwestern University, Cornell University and other institutes recently introduced a new strategy to control the crystallization process in perovskite-based solar cells, stabilizing the δ-phase while facilitating their transition to the α-phase. Their proposed approach, outlined in a paper in Nature Energy, enables the formation of Lewis bases on perovskites on demand to optimize crystallization, which can enhance the efficiency and stability of solar cells.
Increasingly stricter regulations on emissions from lean-burn engines, such as the Euro 7 standard, are approaching. This requires the development of catalytic materials that can reduce the toxic nitrogen oxides efficiently at low temperatures. Researchers at the Department of Physics at Chalmers University of Technology, together with industrial partner Umicore, now present a study showing how machine learning could help engines run cleaner.
Catalytic converters reduce the amount of toxic pollutants emitted into the air from a vehicle’s exhaust system. Stricter regulations on emissions standards within the coming years, such as the European Union’s proposed Euro 7, aim at further reducing air pollution from vehicles. Therefore, improved catalysts are needed to limit the emissions of harmful pollutants.
The main technology of selective catalytic reduction of nitrogen oxides uses ammonia as a reducing agent. Thus, the catalytic material should promote the formation of a nitrogen–nitrogen bond between nitrogen oxides and ammonia in an oxygen-rich environment and prevent unwanted reactions, which include the oxidation of ammonia to even more nitrogen oxides or nitrous oxide.
Scientists are racing against time to try and create revolutionary, sustainable energy sources (such as solid-state batteries) to combat climate change. However, this race is more like a marathon, as conventional approaches are trial-and-error in nature, typically focusing on testing individual materials and set pathways one by one.
To get us to the finish line faster, researchers at Tohoku University developed a data-driven AI framework that points out potential solid-state electrolyte (SSE) candidates that could be “the one” to create the ideal sustainable energy solution.
This model does not only select optimal candidates, but can also predict how the reaction will occur and why this candidate is a good choice—providing interesting insights into potential mechanisms and giving researchers a huge head start without even stepping foot into the lab.
Researchers at Korea’s Daegu Gyeongbuk Institute of Science and Technology (DGIST) have developed a porous laser-induced graphene (LIG) sensor array that functions as a “next-generation AI electronic nose” capable of distinguishing scents like the human olfactory system does and analyzing them using artificial intelligence.
This technology converts scent molecules into electrical signals and trains AI models on their unique patterns. It holds great promise for applications in personalized health care, the cosmetics industry, and environmental monitoring.
While conventional electronic noses (e-noses) have already been developed and used in areas such as food safety and gas detection in industrial settings, they struggle to distinguish subtle differences between similar smells or analyze complex scent compositions. For instance, distinguishing among floral perfumes with similar notes or detecting the faint odor of fruit approaching spoilage remains challenging for current systems. This gap has driven demand for next-generation e-nose technologies with greater precision, sensitivity, and adaptability.
Northwestern University engineers have developed a pacemaker so tiny that it can fit inside the tip of a syringe — and be non-invasively injected into the body.
Smaller than a single grain of rice, the pacemaker is paired with a small, soft, flexible, wireless, wearable device that mounts onto a patient’s chest to control pacing. When the wearable device detects an irregular heartbeat, it automatically shines a light pulse to activate the pacemaker. These short pulses— which penetrate through the patient’s skin, breastbone and muscles — control the pacing. #Repost
Although it can work with hearts of all sizes, the pacemaker is particularly well-suited to the tiny, fragile hearts of newborn babies with congenital heart defects.
Designed for patients who only need temporary pacing, the pacemaker simply dissolves after it’s no longer needed. All the pacemaker’s components are biocompatible, so they naturally dissolve into the body’s biofluids, bypassing the need for surgical extraction.
Four children have gained life-changing improvements in sight following treatment with a pioneering new genetic medicine through Moorfields Eye Hospital and UCL Institute of Ophthalmology.
The work was funded by the NIHR Research Professorship, Meira GTx and Moorfields Eye Charity.
The 4 children were born with a severe impairment to their sight due to a rare genetic deficiency that affects the ‘AIPL1’ gene. The defect causes the retinal cells to malfunction and die. Children affected are only able to distinguish between light and darkness. They are legally certified as blind from birth.
The new treatment is designed to enable the retinal cells to work better and to survive longer. The procedure, developed by UCL scientists, consists of injecting healthy copies of the gene into the retina through keyhole surgery. These copies are contained inside a harmless virus, so they can penetrate the retinal cells and replace the defective gene.
The condition is very rare, and the first children identified were from overseas. To mitigate any potential safety issues, the first 4 children received this novel therapy in only one eye.
The eye gene therapy was delivered via keyhole surgery at Great Ormond Street Hospital. The children were assessed in the NIHR Moorfields Clinical Research Facility, and the NIHR Moorfields Biomedical Research Centre provided infrastructure support for the research.
Complete the security check before continuing. This step verifies that you are not a bot, which helps to protect your account and prevent spam.
In a large population-based cohort of individuals who underwent electron-beam CT, coronary artery calcium score was independently associated with incident lung cancer diagnosis but did not demonstrate potential to improve risk stratification in lung cancer screening.
Senolytics can prevent and treat age-related diseases in mice, but data in humans are lacking — for now.